Disrupting.Healthcare is an independent publication focused on the future of health technology, with a particular emphasis on MedTech, digital therapeutics, and commercial strategy in the European life sciences sector. It covers the intersection of innovation, policy, commercialization, and clinical adoption — offering data-driven insights for founders, investors, and industry insiders.
This platform exists to demystify complex healthcare innovation by highlighting what works, what doesn’t, and where the industry is heading — without jargon, hype, or corporate fluff.
Editorial Policy
All content is researched, written, and curated by Piotr Wrzosinski, a seasoned expert in digital health and MedTech marketing, with over two decades of experience across consulting, pharma, and medical devices.
While we strive for accuracy, relevance, and actionability, all views expressed are personal and do not represent the positions of Piotr’s current or past employers.
Sources: We reference public data, peer-reviewed literature, regulatory databases (e.g., FDA, EMA), and reputable industry reports (e.g., McKinsey, Accenture, IQVIA, Deloitte, Rock Health).
The content may be enhanced and cocreated with GenAI tools, and if this is a case it is always mentioned in the article.
Editorial Independence: This site does not accept sponsored content or paid placement.
Content Integrity: Posts are based on verified data and practical experience. Speculative content is clearly labeled as such.
Feedback & Corrections: Readers are encouraged to flag any errors or omissions via comments or e-mail.
The content of this website is not a financial, legal or medical advice.